Clinical and Laboratory Findings in Patients with δ-Storage Pool Disease: A Case Series

Abstract

Platelet δ-storage pool disease (δ-SPD) is a platelet function disorder characterized by a reduction in the number or content of dense granules. Reports on δ-SPD are mostly limited to case presentations. We aimed to retrospectively describe a series of patients with δ-SPD to better characterize the disease. We studied 16 patients with congenital or acquired δ-SPD. Lumiaggregometry, α- and δ-granules content, platelet ultrastructure, α_IIbβ₃ integrin, and glycoprotein Ib (GPIb) activation were assessed. Most of the patients generally demonstrate mild to moderate bleeding diathesis. Platelet aggregation studies showed moderate abnormalities with variable profiles, while all the individuals had almost complete absence of adenosine triphosphate release. Mepacrine capture, CD63 expression, and study of dense granules by electron microscopy enabled to distinguish different subtypes of δ-SPD with quantitative or qualitative defect. Surprisingly, significantly decreased GPIb expression levels after platelet activation with thrombin receptor activating peptide 50 μM were found, suggesting that GPIb-impaired mobilization may represent an additional feature of the disorder. In conclusion, δ-SPD represents a complex disorder with various clinical and biological aspects, requiring a great deal of expertise to be properly diagnosed.

Keywords

platelet δ-storage pool disease - dense granules - bleeding score - platelet function testing - electron microscopy

• References

• 1 Gremmel T, Frelinger III AL, Michelson AD. Platelet physiology. Semin Thromb Hemost 2016; 42 (3) 191-204
• 2 Guerrero JA, Bennett C, van der Weyden L , et al. Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice. Blood 2014; 124 (24) 3624-3635
• 3 von Papen M, Gambaryan S, Schütz C, Geiger J. Determination of ATP and ADP secretion from human and mouse platelets by an HPLC assay. Transfus Med Hemother 2013; 40 (2) 109-116
• 4 Ruiz FA, Lea CR, Oldfield E, Docampo R. Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem 2004; 279 (43) 44250-44257
• 5 Masliah-Planchon J, Darnige L, Bellucci S. Molecular determinants of platelet delta storage pool deficiencies: an update. Br J Haematol 2013; 160 (1) 5-11
• 6 Bolton-Maggs PH, Chalmers EA, Collins PW , et al; UKHCDO. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006; 135 (5) 603-633
• 7 Mumford AD, Frelinger III AL, Gachet C , et al. A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders. Thromb Haemost 2015; 114 (1) 14-25
• 8 Cai H, Mullier F, Frotscher B , et al. Usefulness of flow cytometric mepacrine uptake/release combined with CD63 Assay in diagnosis of patients with suspected platelet dense granule disorder. Semin Thromb Hemost 2016; 42 (3) 282-291
• 9 Lowe GC, Sánchez Guiu I, Chapman O , et al; UK GAPP collaborative. Microsatellite markers as a rapid approach for autozygosity mapping in Hermansky-Pudlak syndrome: identification of the second HPS7 mutation in a patient presenting late in life. Thromb Haemost 2013; 109 (4) 766-768
• 10 Kurnik K, Bartsch I, Maul-Pavicic A , et al. Novel mutation in Hermansky-Pudlak syndrome type 2 with mild immunological phenotype. Platelets 2013; 24 (7) 538-543
• 11 Cattaneo M, Lecchi A, Agati B, Lombardi R, Zighetti ML. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thromb Res 1999; 96 (3) 213-217
• 12 Pujol-Moix N, Hernández A, Escolar G, Español I, Martínez-Brotóns F, Mateo J. Platelet ultrastructural morphometry for diagnosis of partial delta-storage pool disease in patients with mild platelet dysfunction and/or thrombocytopenia of unknown origin. A study of 24 cases. Haematologica 2000; 85 (6) 619-626
• 13 Gordon N, Thom J, Cole C, Baker R. Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol 1995; 89 (1) 117-123
• 14 Rodeghiero F, Tosetto A, Abshire T , et al; ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8 (9) 2063-2065
• 15 Cattaneo M, Cerletti C, Harrison P , et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost 2013;
• 16 White JG. Use of the electron microscope for diagnosis of platelet disorders. Semin Thromb Hemost 1998; 24 (2) 163-168
• 17 Pareti FI, Gugliotta L, Mannucci L, Guarini A, Mannucci PM. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb Haemost 1982; 47 (2) 84-89
• 18 Mouly S, Youssefian T, Souni F , et al. Acquired delta-storage pool deficiency associated with idiopathic myelofibrosis. Leuk Lymphoma 2000; 37 (5–6) 623-627
• 19 Mohri H. Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia. Am J Hematol 1986; 22 (4) 391-401
• 20 Gerrard JM, McNicol A. Platelet storage pool deficiency, leukemia, and myelodysplastic syndromes. Leuk Lymphoma 1992; 8 (4–5) 277-281
• 21 Soslau G, Brodsky I. Hereditary sideroblastic anemia with associated platelet abnormalities. Am J Hematol 1989; 32 (4) 298-304
• 22 Manoharan A, Brighton T, Gemmell R, Lopez K, Moran S, Kyle P. Platelet dysfunction in myelodysplastic syndromes: a clinicopathological study. Int J Hematol 2002; 76 (3) 272-278
• 23 Malpass TW, Savage B, Hanson SR, Slichter SJ, Harker LA. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders. J Lab Clin Med 1984; 103 (6) 894-904
• 24 Weiss HJ, Rosove MH, Lages BA, Kaplan KL. Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases. Am J Med 1980; 69 (5) 711-717
• 25 Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007; 21 (1) 21-36
• 26 Kahr WH, Lo RW, Li L , et al. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood 2013; 122 (19) 3349-3358
• 27 Ozaki K, Fujimori H, Nomura S , et al. Morphologic and hematologic characteristics of storage pool deficiency in beige rats (Chédiak-Higashi syndrome of rats). Lab Anim Sci 1998; 48 (5) 502-506
• 28 Nieuwenhuis HK, Akkerman JW, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood 1987; 70 (3) 620-623
• 29 Jedlitschky G, Cattaneo M, Lubenow LE , et al. Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol 2010; 176 (3) 1097-1103
• 30 Lages B, Holmsen H, Weiss HJ, Dangelmaier C. Thrombin and ionophore A23187-induced dense granule secretion in storage pool deficient platelets: evidence for impaired nucleotide storage as the primary dense granule defect. Blood 1983; 61 (1) 154-162
• 31 Weiss HJ, Lages B. Studies of thromboxane B2, platelet factor 4, and fibrinopeptide A in bleeding-time blood of patients deficient in von Willebrand factor, platelet glycoproteins Ib and IIb-IIIa, and storage granules. Blood 1993; 82 (2) 481-490
• 32 Maurer-Spurej E, Pittendreigh C, Wu JK. Diagnosing platelet delta-storage pool disease in children by flow cytometry. Am J Clin Pathol 2007; 127 (4) 626-632
• 33 Harrison P, Mackie I, Mumford A , et al; British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 2011; 155 (1) 30-44